Cinctive Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$259K Buy
+3,281
New +$279K 0.01% 395
2025
Q1
– Sell
-23,138
Closed -$1.91M – 374
2024
Q4
$1.91M Buy
+23,138
New +$1.82M 0.1% 222
2024
Q1
– Sell
-16,345
Closed -$871K – 442
2023
Q4
$871K Buy
+16,345
New +$797K 0.06% 262
2023
Q2
– Sell
-105,017
Closed -$5.95M – 416
2023
Q1
$5.95M Buy
+105,017
New +$6.73M 0.2% 179
2021
Q4
– Sell
-88,054
Closed -$6.75M – 581
2021
Q3
$6.75M Buy
88,054
+38,453
+78% +$3.09M 0.33% 83
2021
Q2
$3.85M Buy
+49,601
New +$3.53M 0.18% 179
2020
Q1
– Sell
-54,108
Closed -$3.19M – 234
2019
Q4
$3.19M Buy
+54,108
New +$2.94M 0.33% 129

Other funds holding GMED

Cinctive Capital Management's GMED Position: Q2 2026 in Review

Cinctive Capital Management opened a new position in Globus Medical (GMED) in Q2 2026: 3,281 shares worth $259K. The stake represents 0.01% of the portfolio and ranks #395 among its holdings. This is a return to the name: Cinctive Capital Management previously reported a position in GMED as recently as Q4 2024.

Cinctive Capital Management first reported a position in GMED in Q4 2019 and has held it in 7 quarters since. The position peaked at $6.75M in Q3 2021. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cinctive Capital Management held 3,281 shares of Globus Medical worth $259K as of Q2 2026.
  • Globus Medical was a new Cinctive Capital Management position in Q2 2026.
  • Globus Medical made up 0.01% of Cinctive Capital Management's portfolio in Q2 2026, its #395 holding.
  • Cinctive Capital Management first reported a position in Globus Medical in Q4 2019 and has held it in 7 quarters since.
  • Cinctive Capital Management's Globus Medical position peaked at $6.75M in Q3 2021.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.